Daily FNArena News - Small Caps

Carbon capture and biofuel production pioneer Algae.Tec has signed a deal with NSW’ largest coal-fired power station to construct an adjacent capture/production facility, believed to be a wold-first for coal-related industry.

Austin Exploration is making progress in highly prospective areas of the Eagle Ford and Niobrara unconventional oil and gas regions.

REVA Medical has commenced recruiting for a CE Mark trial of its new stent product, which has Bell Potter assessing the potential of the stock.

Composites manufacturer Quickstep has not been disadvantaged by government indecision on either side of the Pacific over the new Joint Strike Fighter, but rather has used the time to its own advantage.

Microequities suggests recent weakness for Vocus Communication ignores earnings growth potential from acquisitions and the rollout of the company’s fibre network.

The market responded hastily and impatiently to BigAir’s weak FY13 result, rails Microequities, given acquisitions will really hit their straps in FY14.

As the population of diabetics increases alarmingly a company with a device to control the disease has the world at its feet.

Microcap specialist Microequities explains why it remains at arm’s length from software company Corum Ltd.

Biotech stock Bionomics is undervalued as its therapeutics program has been enhanced with the acquisition of Eclipse, according to Bell Potter.

Integrated Research offers opportunity for exposure to high tech arena, according to Moelis.